Neurologic manifestations are common in children hospitalized with SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C), ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...

Scientists documented a rare case of COVID-19 persisting for over 750 days in a man with advanced HIV. The virus, confined ...

Microbes in water are like invisible travelers—and some carry disease with them. Keeping the water that flows through our ...

A man living with advanced HIV carried COVID-19 for more than 750 days. During the chronic infection, the virus mutated ...

Ms. Kuhl will lead the Company’s communications and patient advocacy efforts as Invivyd advances its mission of providing monoclonal antibodies for the prevention and treatment of viral disease. Ms.

The Democratic Republic of the Congo (DRC) has declared a new Ebola outbreak in Kasai Province. It’s caused by the most ...

A new study published in the journal of Clinical Infectious Diseases showed that daily use of interferon-alpha (IFN-α) nasal ...

The disease is highly contagious through direct contact with blood, secretions, or other body fluids of infected people or ...

Moderna shares rose by over 4% on a mixed Tuesday for US equities ahead of the US Federal Reserve's rate cut decision today.

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 ...

With confusion about eligibility for COVID-19 vaccines, Gov. Gretchen Whitmer is expected to sign an executive directive ...